[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsControl group: Individuals in the control group receive only the recommended national hydroxychloroquine diet as a single dose and then daily consumption of Coltra.dose and then daily consumption of Kaletra.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIndividuals in the intervention group approved by the nationally approved hydroxychloroquine regimen as a single dose and then daily administration of Kaletra and in addition to the above treatment with interferon beta-one B (at a dose of 250 micrograms or 8 million subcutaneously every other day). Beta is a subsidiary of Iran Pharmaceutical Company.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 672, "treatment_name": "Interferon beta 1b", "treatment_type": "Interferons", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]